RNA28SN4 |
|
RNA, 28S ribosomal N4
|
|
|
0.805 |
0.231 |
RNA28S5 |
|
RNA, 28S ribosomal 5
|
|
|
0.805 |
0.231 |
IGKV3-20 |
P01619
|
immunoglobulin kappa variable 3-20
|
Immune response
|
|
0.736 |
0.308 |
RNA28SN5 |
|
RNA, 28S ribosomal N5
|
|
|
0.705 |
0.346 |
FCRL5 |
Q96RD9
|
Fc receptor like 5
|
Cell adhesion
|
4.6E-17 |
0.722 |
0.462 |
ZFP36L2 |
P47974
|
ZFP36 ring finger protein like 2
|
Nucleic acid binding
|
0.97 |
0.686 |
0.500 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
MLLT11 |
Q13015
|
MLLT11 transcription factor 7 cofactor
|
|
0.53 |
0.633 |
0.500 |
PLK3 |
Q9H4B4
|
polo like kinase 3
|
Kinase
|
1.9E-06 |
0.644 |
0.538 |
EPS8 |
Q12929
|
epidermal growth factor receptor pathway substrate 8
|
Receptor
|
0.97 |
0.608 |
0.615 |
ID4 |
P47928
|
inhibitor of DNA binding 4, HLH protein
|
Transcription factor
|
3.1E-02 |
0.590 |
0.615 |
PTK7 |
Q13308
|
protein tyrosine kinase 7 (inactive)
|
Kinase
|
1.00 |
0.568 |
0.615 |
MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
PAX5 |
Q02548
|
paired box 5
|
|
1.00 |
0.487 |
0.654 |
ASPG |
Q86U10
|
asparaginase
|
|
6.2E-13 |
0.559 |
0.654 |
PIM3 |
Q86V86
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
0.98 |
0.621 |
0.654 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |
E2F4 |
Q16254
|
E2F transcription factor 4
|
Nucleic acid binding
|
0.45 |
0.599 |
0.692 |
FLI1 |
Q01543
|
Fli-1 proto-oncogene, ETS transcription factor
|
Transcription factor
|
0.99 |
0.468 |
0.692 |
COG1 |
Q8WTW3
|
component of oligomeric golgi complex 1
|
|
4.9E-08 |
0.628 |
0.692 |
DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |